Follow
Juxiang Cao
Juxiang Cao
Brigham and Women's Hospital, Harvard Medical School
Verified email at bu.edu
Title
Cited by
Cited by
Year
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
J Cao, J Schulte, A Knight, NR Leslie, A Zagozdzon, R Bronson, ...
The EMBO journal 28 (10), 1505-1517, 2009
3952009
Peroxiredoxin 1 and its role in cell signaling
CA Neumann, J Cao, Y Manevich
Cell cycle 8 (24), 4072-4078, 2009
2702009
MC1R is a potent regulator of PTEN after UV exposure in melanocytes
J Cao, L Wan, E Hacker, X Dai, S Lenna, C Jimenez-Cervantes, Y Wang, ...
Molecular cell 51 (4), 409-422, 2013
1612013
Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas
F Liu, J Cao, J Wu, K Sullivan, J Shen, B Ryu, Z Xu, W Wei, R Cui
Journal of Investigative Dermatology 133 (8), 2041-2049, 2013
1292013
GABA shunt mediates thermotolerance in Saccharomyces cerevisiae by reducing reactive oxygen production
J Cao, JM Barbosa, NK Singh, RD Locy
Yeast 30 (4), 129-144, 2013
812013
Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway
H Potu, LF Peterson, A Pal, M Verhaegen, J Cao, M Talpaz, NJ Donato
Oncotarget 5 (14), 5559, 2014
702014
The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function
L Wan, M Chen, J Cao, X Dai, Q Yin, J Zhang, SJ Song, Y Lu, J Liu, ...
Cancer discovery 7 (4), 424-441, 2017
632017
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation
J Cao, ME Tyburczy, J Moss, TN Darling, HR Widlund, DJ Kwiatkowski
The Journal of clinical investigation 127 (1), 349-364, 2017
602017
FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription
L Dong, Y Li, J Cao, F Liu, E Pier, J Chen, Z Xu, C Chen, RA Wang, R Cui
Cell Death & Differentiation 19 (4), 616-622, 2012
472012
Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation
A Takashima, B English, Z Chen, J Cao, R Cui, RM Williams, DV Faller
ACS chemical biology 9 (4), 1003-1014, 2014
302014
TBX 2 expression is regulated by PAX 3 in the melanocyte lineage
F Liu, J Cao, J Lv, L Dong, E Pier, GX Xu, R Wang, Z Xu, C Goding, R Cui
Pigment cell & melanoma research 26 (1), 67-77, 2013
242013
The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth
J Cao
Science signaling, 0
23*
The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function. Cancer Discov. 2017; 7: 424–441. doi: 10.1158/2159-8290
L Wan, M Chen, J Cao, X Dai, Q Yin, J Zhang, SJ Song, Y Lu, J Liu, ...
CD-16-0647.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
16
GABA transaminases from Saccharomyces cerevisiae and Arabidopsis thaliana complement function in cytosol and mitochondria
J Cao, JM Barbosa, N Singh, RD Locy
Yeast 30 (7), 279-289, 2013
142013
Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1
JJ Skoko, J Cao, D Gaboriau, M Attar, A Asan, L Hong, CE Paulsen, H Ma, ...
Redox biology 56, 102443, 2022
112022
Studies on the genetic diversity of Rhizoctonia solani AG-1-IA from six provinces in the southern China
Z Erxun, C Juxiang, Y Mei, Z Xiru
Journal of Nanjing Agricultural University 25 (3), 36-40, 2002
102002
Characterization of the recombinant succinic semi‐aldehyde dehydrogenase from Saccharomyces cerevisiae
J Cao, NK Singh, RD Locy
Yeast 31 (10), 411-420, 2014
72014
Analysis of a mouse skin model of tuberous sclerosis complex
Y Guo, JR Dreier, J Cao, H Du, SR Granter, DJ Kwiatkowski
Plos one 11 (12), e0167384, 2016
42016
Deubiquitinases Usp9x and Usp5 control tumorigenicity and apoptotic responsiveness in malignant melanoma
H Potu, A Pal, H Sun, L Peterson, M Talpaz, M Verhaegen, J Cao, ...
Cancer Research 74 (19_Supplement), 4435-4435, 2014
22014
Loss of PRDX1 increases RAD51 Cys319 oxidation and decreases homologous recombination
J Skoko, A Asan, C Woodcock, J Cao, D Gaboriau, C Paulsen, M Attar, ...
Free Radical Biology and Medicine 128, S73-S74, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20